...
首页> 外文期刊>American Journal of Physiology >Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line.
【24h】

Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line.

机译:人肠道细胞系中寡肽转运蛋白pept-1的激素调节。

获取原文
获取原文并翻译 | 示例

摘要

The intestinal oligopeptide transporter (cloned as Pept-1) has major roles in protein nutrition and drug therapy. A key unstudied question is whether expression of Pept-1 is hormonally regulated. In this experiment, we investigated whether insulin has such a role. We used a human intestinal cell monolayer (Caco-2) as the in vitro model of human small intestine and glycylglutamine (Gly-Gln) as the model substrate for Pept-1. Results showed that addition of insulin at a physiological concentration (5 nM) to incubation medium greatly stimulates Gly-Gln uptake by Caco-2 cells. This stimulation was blocked when genistein, an inhibitor of tyrosine kinase, was added to incubation medium. Studies of the mechanism of insulin stimulation showed the following. 1) Stimulation occurred promptly (30-60 min) after exposure to insulin. 2) There was no significant change in the Michaelis-Menten constant of Gly-Gln transport, but there was a nearly twofold increase in its maximal velocity. 3) Insulin effect persisted even when Golgi apparatus, which is involved in trafficking of newly synthesized Pept-1, was dismantled. 4) However, there was complete elimination of insulin effect by disruption of microtubules involved in trafficking of preformed Pept-1. 5) Finally, with insulin treatment, there was no change in Pept-1 gene expression, but the amount of Pept-1 protein in the apical membrane was increased. In conclusion, the results show that insulin, when it binds to its receptor, stimulates Gly-Gln uptake by Caco-2 cells by increasing the membrane population of Pept-1. The mechanism appears to be increased translocation of this transporter from a preformed cytoplasmic pool.
机译:肠道寡肽转运蛋白(克隆为Pept-1)在蛋白质营养和药物治疗中起主要作用。尚未研究的关键问题是Pept-1的表达是否受到激素调节。在该实验中,我们调查了胰岛素是否具有这种作用。我们使用人肠道细胞单层(Caco-2)作为人小肠的体外模型,并使用甘氨酰谷氨酰胺(Gly-Gln)作为Pept-1的模型底物。结果表明,将生理浓度(5 nM)的胰岛素添加到培养培养基中会极大地刺激Caco-2细胞摄取Gly-Gln。当染料木黄酮(酪氨酸激酶的抑制剂)被添加到培养液中时,这种刺激被阻断。对胰岛素刺激机制的研究显示如下。 1)接触胰岛素后立即(30-60分钟)发生刺激。 2)Gly-Gln转运的Michaelis-Menten常数没有显着变化,但是其最大速度几乎增加了两倍。 3)即使拆除涉及新合成的Pept-1的运输的高尔基体,胰岛素作用仍然持续。 4)然而,通过破坏与预先形成的Pept-1的运输有关的微管的破坏,胰岛素作用被完全消除。 5)最后,在胰岛素治疗下,Pept-1基因表达没有变化,但是顶端膜中Pept-1蛋白的量增加了。总之,结果表明,当胰岛素与其受体结合时,胰岛素会通过增加Pept-1的膜数量来刺激Caco-2细胞摄取Gly-Gln。该机制似乎是增加了该转运蛋白从预先形成的细胞质库中的易位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号